HERON THERAPEUTICS, INC. /DE/ Asset Impairment Charges
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Asset Impairment Charges of $4.27 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2024-11-12
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for the quarter ending 2024-09-30 was $828.00K, a 437.66% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for the quarter ending 2024-06-30 was $3.27M, a 2010.32% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for the quarter ending 2024-03-31 was $170.00K, a 10.39% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for the quarter ending 2023-12-31 was $154.00K, a 94.94% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for fiscal 2023 was $617.00K, a 195.22% increase from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for fiscal 2022 was $209.00K, a 56.28% decline from fiscal 2021.
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for fiscal 2021 was $478.00K, a 43.57% decline from fiscal 2020.
- HERON THERAPEUTICS, INC. /DE/ asset impairment charges for fiscal 2020 was $847.00K, a 691.59% increase from fiscal 2019.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2024-09-30 | $828.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.10M derived: sum of 2 quarters · filed 2024-11-12 | $4.27M 10-Q · filed 2024-11-12 | $4.42M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.44M 10-Q · filed 2024-08-06 | $3.60M derived: sum of 3 quarters · filed 2024-08-06 | $3.75M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $170.00K 10-Q · filed 2024-05-07 | $324.00K derived: sum of 2 quarters · filed 2024-05-07 | $478.00K derived: sum of 3 quarters · filed 2024-11-12 | $633.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $308.00K derived: sum of 2 quarters · filed 2024-11-12 | $463.00K derived: sum of 3 quarters · filed 2024-11-12 | $617.00K 10-K · filed 2024-03-12 |
| 2023-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $309.00K derived: sum of 2 quarters · filed 2024-11-12 | $463.00K 10-Q · filed 2024-11-12 | $542.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $309.00K 10-Q · filed 2024-08-06 | $388.00K derived: sum of 3 quarters · filed 2024-08-06 | $430.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $154.00K 10-Q · filed 2024-05-07 | $233.00K derived: sum of 2 quarters · filed 2024-05-07 | $275.00K derived: sum of 3 quarters · filed 2024-05-07 | $316.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $121.00K derived: sum of 2 quarters · filed 2024-03-12 | $162.00K derived: sum of 3 quarters · filed 2024-03-12 | $209.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $83.00K derived: sum of 2 quarters · filed 2023-11-14 | $130.00K 10-Q · filed 2023-11-14 | $254.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $88.00K 10-Q · filed 2023-08-14 | $212.00K derived: sum of 3 quarters · filed 2023-08-14 | $376.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $47.00K 10-Q · filed 2023-05-11 | $171.00K derived: sum of 2 quarters · filed 2023-05-11 | $335.00K derived: sum of 3 quarters · filed 2023-05-11 | $445.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $288.00K derived: sum of 2 quarters · filed 2023-03-29 | $398.00K derived: sum of 3 quarters · filed 2023-03-29 | $478.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $274.00K derived: sum of 2 quarters · filed 2022-11-08 | $354.00K 10-Q · filed 2022-11-08 | $1.14M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $190.00K 10-Q · filed 2022-08-09 | $976.00K derived: sum of 3 quarters · filed 2022-08-09 | $984.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $80.00K 10-Q · filed 2022-05-09 | $866.00K derived: sum of 2 quarters · filed 2022-05-09 | $874.00K derived: sum of 3 quarters · filed 2022-05-09 | $900.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $786.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $794.00K derived: sum of 2 quarters · filed 2022-02-28 | $820.00K derived: sum of 3 quarters · filed 2022-02-28 | $847.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $34.00K derived: sum of 2 quarters · filed 2021-11-03 | $61.00K 10-Q · filed 2021-11-03 | $88.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $53.00K 10-Q · filed 2021-08-09 | $80.00K derived: sum of 3 quarters · filed 2022-02-28 | $106.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $27.00K 10-Q · filed 2021-05-10 | $54.00K derived: sum of 2 quarters · filed 2022-02-28 | $80.00K derived: sum of 3 quarters · filed 2022-02-28 | $107.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $53.00K derived: sum of 2 quarters · filed 2022-02-28 | $80.00K derived: sum of 3 quarters · filed 2022-02-28 | $107.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $53.00K derived: sum of 2 quarters · filed 2020-11-05 | $80.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $54.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $27.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $72.00K 10-K · filed 2021-02-24 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-05-10 | $0.00 derived: sum of 3 quarters · filed 2018-05-10 | $0.00 derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-06 | $0.00 derived: sum of 2 quarters · filed 2017-11-06 | $0.00 10-Q · filed 2017-11-06 | $0.00 derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $0.00 derived: sum of 3 quarters · filed 2018-05-10 | $0.00 derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2018-05-10 | $0.00 derived: sum of 3 quarters · filed 2018-05-10 | $0.00 derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-06 | $0.00 derived: sum of 2 quarters · filed 2017-11-06 | $0.00 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 | |||
| 2014-12-31 | $905.00K 10-K · filed 2017-02-23 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |